Sustainability in Preanalytics
Dr. Mads Nybo presents:
- Release Date: 01.04.2025
- Duration: 33 minutes
- Guest: Dr. Mads Nybo
- Host: Director Global Medical & Clinical Affairs Ana-Maria Å imundiÄ
- Introduction: Dr. Mads Nybo, chief physician at the Clinical Biochemistry department of the Odense University Hospital shares his views on and experience with sustainability in the medical sector.
Timestamps for Episode 3
- 01:33 - Sustainability is very much the word on the agenda
- 02:50 - Looking at Preanalytics from a sustainable point of view
- 04:53- The situation in Denmark
- 06:20- Finding a systematic approach
- 08:08- Laboratory solutions already in practice
- 10:45 - The demand management concept and low volume tubes
- 19:30 - Waste in laboratories
- 21:49 - Could blood collection tubes be circular?
What You Can't Miss – In a Nutshell
As an industry, we can do a lot
- We have a shared responsibility, not just in the industry but also on the laboratory side. It's not always possible to see what to do from the outside, so we have an obligation to make things more sustainable.
We need to put on a different pair of glasses
- We are used to looking at laboratory processes solely from a productivity and flow-oriented perspective. For sustainability, we need to foster collaboration between laboratories, medical specialties and the industry. If we re-think our processes, there are improvement possibilites along the way.
Recycling: PET material for tubes is high quality, we should aim to recycle it
- A project with Odense hospital has proven that that used blood tubes can be decontaminated. Biohazardous waste becomes just waste. The next step will be to successfully recycle and reuse the material for new tubes.
āWe are sitting in the middle of the machinery. So if we as laboratory professionals can come up with some ideas that we could give to politicians or to the industry, that's our obligation.ā
Get the latest from our podcast
Disclaimer & Shownotes
The guests interviewed in this podcast share their individual experiences with the use of our or comparable products and/or services. The opinions expressed are those of the interviewee and do not claim to represent the opinions or views of Greiner Bio-One. This information partially reflects the opinions of our customers and/or the experiences of individuals and does not claim to represent the opinions or views of Greiner Bio-One.
Products from Greiner Bio-One should only be used by appropriately trained medical professionals in accordance with the relevant instructions for use (IFU). A list of indications, contraindications, precautions, and warnings can be found in the instructions for use that accompany each product or can be downloaded from our website www.gbo.com (Download Center). For further information, please contact your local Greiner Bio-One distributor or visit our website.
All information is provided without guarantee despite careful processing. Liability, warranty, or guarantee of Greiner Bio-One GmbH is excluded. All rights, errors, and changes are reserved. Unless otherwise stated, Greiner Bio-One GmbH holds all copyrights and/or other (usage) rights in the present documents, especially to trademarks, such as the listed (word-image) marks, logos. Any use, reproduction, or other use of the rights of Greiner Bio-One GmbH is expressly prohibited.
Publisher and editor: Greiner Bio-One GmbH, Bad Haller Str. 32, 4550 KremsmĆ¼nster, Austria.
Assiamira Ferrara, Monique M. Hedderson, Charles P. Quesenberry, Joseph V. Selby; Prevalence of Gestational Diabetes Mellitus Detected by the National Diabetes Data Group or the Carpenter and Coustan Plasma Glucose Thresholds. Diabetes Care 1 September 2002; 25 (9): 1625ā1630. doi.org/10.2337/diacare.25.9.1625
diabetesjournals.org/care/article/25/9/1625/21728/Prevalence-of-Gestational-Diabetes-Mellitus
